Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike A Cornejo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bioconjugate Chemistry|September 22, 2023
Click Chemistry and Radiochemistry: An UpdateDavid Bauer, Mike A Cornejo, Tran T Hoang, et al.
ACS Nano|January 29, 2019
Customizing Morphology, Size, and Response Kinetics of Matrix Metalloproteinase-Responsive Nanostructures by Systematic Peptide DesignJiye Son, Daniela Kalafatovic, Mohit Kumar, et al.
European Journal of Medicinal Chemistry|October 28, 2018
Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancerBenelita T Elie, Jacob Fernández-Gallardo, Natalia Curado, et al.
International Journal of Radiation Biology|June 20, 2025
Exploring Auger electron-emitting radionuclides for targeted DNA damage in mismatch repair-deficient cells: a theoretical study of <sup>99</sup>Rh- and <sup>123</sup>I-labeled metalloinsertorsAlexandre França Velo, Lukas Carter, Michael Bellamy, et al.
Chemmedchem|March 30, 2019
Preparation of Titanocene-Gold Compounds Based on Highly Active Gold(I)-N-Heterocyclic Carbene Anticancer Agents: Preliminary in vitro Studies in Renal and Prostate Cancer Cell LinesNatalia Curado, Nora Giménez, Kirill Miachin, et al.
Molecular Pharmaceutics|January 28, 2026
Pharmacokinetic Optimization of Radiocopper-Based Theranostic PretargetingMike A Cornejo, Zachary V Samuels, Gina Dehlavi, et al.
Journal of Medicinal Chemistry|November 11, 2022
Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic AgentYutian Feng, Samantha M Sarrett, Rebecca L Meshaw, et al.
RSC Advances|June 14, 2023
Site-selective radiolabeling using mushroom tyrosinase and the strain-promoted oxidation-controlled 1,2-quinone cycloadditionCindy Rodriguez, Samantha Delaney, Joni Sebastiano, et al.
RSC Advances|January 22, 2026
Harnessing Frémy's salt for tyrosine-directed bioconjugationsZachary V Samuels, Ava Stoddard, Wei-Siang Mark Kao, et al.
Nuclear Medicine and Biology|March 6, 2020
Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissueJeroen A C M Goos, Maria Davydova, Thomas R Dilling, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bioconjugate Chemistry|September 22, 2023
Click Chemistry and Radiochemistry: An UpdateDavid Bauer, Mike A Cornejo, Tran T Hoang, et al.
ACS Nano|January 29, 2019
Customizing Morphology, Size, and Response Kinetics of Matrix Metalloproteinase-Responsive Nanostructures by Systematic Peptide DesignJiye Son, Daniela Kalafatovic, Mohit Kumar, et al.
European Journal of Medicinal Chemistry|October 28, 2018
Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancerBenelita T Elie, Jacob Fernández-Gallardo, Natalia Curado, et al.
International Journal of Radiation Biology|June 20, 2025
Exploring Auger electron-emitting radionuclides for targeted DNA damage in mismatch repair-deficient cells: a theoretical study of <sup>99</sup>Rh- and <sup>123</sup>I-labeled metalloinsertorsAlexandre França Velo, Lukas Carter, Michael Bellamy, et al.
Chemmedchem|March 30, 2019
Preparation of Titanocene-Gold Compounds Based on Highly Active Gold(I)-N-Heterocyclic Carbene Anticancer Agents: Preliminary in vitro Studies in Renal and Prostate Cancer Cell LinesNatalia Curado, Nora Giménez, Kirill Miachin, et al.
Molecular Pharmaceutics|January 28, 2026
Pharmacokinetic Optimization of Radiocopper-Based Theranostic PretargetingMike A Cornejo, Zachary V Samuels, Gina Dehlavi, et al.
Journal of Medicinal Chemistry|November 11, 2022
Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic AgentYutian Feng, Samantha M Sarrett, Rebecca L Meshaw, et al.
RSC Advances|June 14, 2023
Site-selective radiolabeling using mushroom tyrosinase and the strain-promoted oxidation-controlled 1,2-quinone cycloadditionCindy Rodriguez, Samantha Delaney, Joni Sebastiano, et al.
RSC Advances|January 22, 2026
Harnessing Frémy's salt for tyrosine-directed bioconjugationsZachary V Samuels, Ava Stoddard, Wei-Siang Mark Kao, et al.
Nuclear Medicine and Biology|March 6, 2020
Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissueJeroen A C M Goos, Maria Davydova, Thomas R Dilling, et al.
Pageof 1